BOUCHERVILLE, QC, Nov. 18, 2025 /CNW/ - LSL PHARMA GROUP INC. (TSXV: LSL) (TSXV: LSL.DB) ("the Company" or "LSL Pharma"), an integrated Canadian pharmaceutical company, is pleased to announce that, further to its press release of July 31, 2025, it has completed the acquisition of Laboratoire Du-Var Inc. ("Du-Var"), a contract manufacturer of cosmetics and natural health products established in 1947.
Read more at newswire.caLSL PHARMA GROUP COMPLETES THE ACQUISITION OF LABORATOIRE DU-VAR INC.
This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.